Trial intelligence / Profile preview

Telmisartan and Low-Glycemic Diet in Abdominal Obesity

NCT00147264Phase 3Completed

Sponsor
McMaster University
Start
Apr 2004
Primary completion
Jan 2006
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of telmisartan in abdominal obesity, metabolic syndrome, sponsored by McMaster University. Started Apr 2004; status: completed.

02

Drugs

telmisartan
03

Conditions

abdominal obesitymetabolic syndrome

Beyond the preview

Go deeper on NCT00147264.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00147264.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call